3DPrint.com July 27, 2023
Vanesa Listek

A new international consortium called HU3DINKS is rallying behind a single mission: to develop advanced human tissue-based bioinks for 3D bioprinting. Supported by IraSME, a German network of funding programs; FFG, Austria’s national funding agency for industrial research and development; and VLAIO, the Flemish agency for innovation and entrepreneurship, the consortium seeks to replace synthetic and animal-derived bioinks, aiming to lead in the bioprinting revolution.

Many bioinks used in bioprinting come from non-human sources, with collagen and gelatin, both animal-derived, being popular choices. While these materials are biocompatible, they have limitations. For instance, the complex mixture of human tissue, including the extracellular matrix (ECM), glycosaminoglycans, or polysaccharides, is hard to replicate.

In its project database, HU3DINKS states that Matrigel, a...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: 3D Printing, Technology
How 3D Printing Impacts Radiology
Ricoh’s 3D Printing Improves Surgical Accuracy and Safety One Layer at a Time
3D-printed hydrogel enables continuous drug delivery via contact lens
Improved 3D printed blood vessels thanks to bioink with DNA
DNA-based bioink technology enables precise 3D-printing of blood vessels

Share This Article